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ABSTRACT Virus capsid proteins must perform a number of roles. These include
self-assembly and maintaining stability under challenging environmental conditions,
while retaining the conformational ﬂexibility necessary to uncoat and deliver the vi-
ral genome into a host cell. Fulﬁlling these roles could place conﬂicting constraints
on the innate abilities encoded within the protein sequences. In a previous study,
we identiﬁed a number of mutations within the capsid-coding sequence of poliovi-
rus (PV) that were established in the population during selection for greater thermo-
stability by sequential treatment at progressively higher temperatures. Two muta-
tions in the VP1 protein acquired at an early stage were maintained throughout this
selection procedure. One of these mutations prevented virion assembly when intro-
duced into a wild-type (wt) infectious clone. Here we show, by sequencing beyond
the capsid-coding region of the heat-selected virions, that two mutations had arisen
within the coding region of the 2A protease. Both mutations were maintained
throughout the selection process. Introduction of these mutations into a wt infec-
tious clone by site-directed mutagenesis considerably reduced replication. However,
they permitted a low level of assembly of infectious virions containing the otherwise
lethal mutation in VP1. The 2Apro mutations were further shown to slow the kinetics
of viral polyprotein processing, and we suggest that this delay improves the correct
folding of the mutant capsid precursor protein to permit virion assembly.
IMPORTANCE RNA viruses, including poliovirus, evolve rapidly due to the error-
prone nature of the polymerase enzymes involved in genome replication. Fixation of
advantageous mutations may require the acquisition of complementary mutations
which can act in concert to achieve a favorable phenotype. This study highlights a
compensatory role of a nonstructural regulatory protein, 2Apro, for an otherwise le-
thal mutation of the structural VP1 protein to facilitate increased thermal resistance.
Studying how viruses respond to selection pressures is important for understanding
mechanisms which underpin emergence of resistance and could be applied to the
future development of antiviral agents and vaccines.
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RNA viruses have high mutation rates that contribute to population diversity, geneticrobustness, and ability to withstand population bottlenecks (1, 2). The RNA-dependent
RNA polymerase enzyme (RdRp) lacks a proofreading function, thereby resulting in error-
prone replication. As a result, RNA viruses exist as swarms of variants, also known as
quasispecies. As viruses adapt under altered growth constraints, mutants with a replicative
advantage in the face of selection emerge from the quasispecies and alter the population
sequence composition. However, this may occur at a cost to virus ﬁtness (1, 3).
Poliovirus (PV), which occurs as three serotypes, PV-1 to -3, is a picornavirus with a
7.5-kb positive-sense, single-stranded RNA genome enclosed within a 30-nm icosahe-
dral capsid. The genome (Fig. 1A) comprises a coding region that is ﬂanked at the 5=
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FIG 1 Identiﬁcation of thermally selected mutations. (A) Cartoon structure of the PV genome, showing the 5= and 3= UTRs ﬂanking the open
reading frame comprising the structural (P1) and nonstructural (P2 and P3) regions. (B) Evolution of PV-1 under thermal selection. Viral RNA
(Continued on next page)
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and 3= ends by untranslated regions (UTR) (4). Upon cell entry, the coding region is
translated into a polyprotein precursor which is cleaved by viral proteases, 2Apro and
3Cpro (or its precursor 3CDpro). Upon translation, the structural precursor protein, P1, is
autocatalytically cleaved from the polyprotein by 2Apro (5), and P1 is further processed
into VP1, VP3, and VP0 by 3Cpro/3CDpro. The two nonstructural precursors, P2 and P3,
are processed into 2Apro, 2B, and 2C and into 3A, 3B, 3Cpro, and 3Dpol, respectively,
again by 3Cpro/3CDpro (6, 7). Replication of the PV genome is mediated by the RdRp
3Dpol (8) and primed by 3B within a membrane-bound complex that also includes 2B
and 2C (9, 10) and 3A (11), whose roles are reviewed in reference 12.
The PV 2Apro is a cysteine protease that has been described as a multifunctional
regulatory protein due to its roles at various stages of the viral life cycle (reviewed in
reference 13). It has an active site that comprises a catalytic triad (H20, D38, and C109)
(14, 15), as well as highly conserved cysteine and histidine residues (C55, C57, C115, and
H117) that have been shown to be critical for maintaining structural integrity and for
cis- and trans-catalytic activities (16, 17). The PV 2Apro has been shown to stimulate
internal ribosome entry site (IRES)-mediated viral translation over cap-dependent trans-
lation of host mRNA through inactivation of a key host cellular translation initiation
factor, eukaryotic initiation factor 4G (eIF4G) (18–20). It has also been shown to have a
role in the control of genome replication by stimulating negative-strand RNA synthesis
and enhancing RNA stability (21, 22). 2Apro also plays a key role in virion assembly (5)
by cleaving the P1 region from the polyprotein. This is followed by the self-assembly of
VP0, VP3, and VP1 into genome-free capsids or around the nascent genome to form
virion particles in which VP0 is cleaved into VP2 and VP4. It has been shown for the
attenuated Sabin vaccine strains of PV-2 and PV-3 that 2Apro can compensate for
cell-speciﬁc attenuating mutations within the 5= UTR (23). Additionally, a study recently
reported on compensatory 2Apro mutations within acid-resistant enterovirus D94 vari-
ants that evolved capsid-stabilizing mutations (24). Together, these ﬁndings suggest
important roles for 2Apro in the evolution of picornaviruses; however, the mechanisms
responsible are unclear.
We recently described the evolution of heat-resistant PV-1 capsids through multiple
cycles of thermal selection (25). Here, we characterized mutations within the nonstruc-
tural protein of the thermally selected virus populations and described the mechanism
by which these facilitated the correct assembly of the heat-resistant capsids.
RESULTS
Analysis of a population of PV-1 evolving during sequential thermal stressing.
Previously, we employed in vitro selection of PV-1 by sequential heating in order to
select mutations in the viral structural proteins that increased the thermal stability of
the capsid (25). Here, we determined the consensus sequence of the evolving popu-
lation at each passage during the selection (Fig. 1B). VP1-V87A was the ﬁrst capsid
mutation observed within the population, following three selection cycles at 51°C. After
ﬁve further cycles of selection at 51°C, VP1-I194V also appeared, after which both
mutations were maintained in the consensus sequences of all subsequent virus pop-
ulations selected at 51°C (VS51), 53°C (VS53), and 57°C (VS57). We introduced each of
FIG 1 Legend (Continued)
was extracted from each passage of virions selected at 51°C (i.e., VS51), 53°C (i.e., VS53), and 57°C (i.e., VS57) (25). The entire genome of the
evolving population at each passage was reverse transcribed and ampliﬁed by PCR. The virus pool was sequenced and aligned against the
wt PV-1 sequence by ClustalOmega. A cartoon representation of selected mutations is shown. Solid black vertical lines represent wt sequences
of the P1 and 2A regions. Nonsynonymous mutations are presented as colored shapes in VP4, VP2, VP3, VP1, and 2Apro, as shown in the key
inset. (C) Sequence comparisons of 2Apro among enteroviruses. Alignment of a 60-residue region of 2Apro of thermally selected viruses VS51,
VS53, and VS57 against enterovirus A (coxsackievirus A1 [CVA-1]), enterovirus B (echovirus 1 [EV1]), enterovirus C (PV-1, PV-2, PV-3, and CVA-2),
enterovirus D: human enterovirus 94 (EV-94); enterovirus E: bovine enterovirus (BEV-1); enterovirus F (BEV-2), enterovirus G (porcine
enterovirus G1 [EV-G1]), enterovirus H (simian enterovirus SV4 [SV4]), rhinovirus A (human rhinovirus A [HRV-A]), rhinovirus B (HRV-B), and
rhinovirus C (HRV-C). Thermally selected virions VS51, VS53, and VS57 are underlined. Enterovirus C members are annotated with a bracket.
The 2Apro consensus residues of wt PV-1 are shown in bold. Matching residues are shown as dots beneath the corresponding residues of wt
PV-1. Variable residues are shown underneath the corresponding positions of the wt PV-1 residues. Asterisks on the consensus sequence
indicate positions that correspond to residues I99 and G102, respectively. Sequences were aligned using the default alignment algorithms of
CLC sequencing viewer version 6.
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the capsid protein mutations identiﬁed in VS51, VS53, and VS57 (Fig. 1B) into an infectious
clone of PV-1 and showed that VP1-I194V alone prevented virus assembly. For these
experiments in vitro-generated T7 RNA transcripts of the mutated genomes were trans-
fected into mouse L cells, and the harvested virions were titrated using HeLa cells (Table 1).
The use of L cells (which do not possess the PV receptor) ensured single-cycle infection.
We extended our sequence analyses beyond P1 and showed that in addition to the
capsid mutations identiﬁed in VS51, two nonstructural mutations were identiﬁed within the
2Apro region of the genome (i.e., 2A-I99V and 2A-G102R) and were maintained in further
rounds of thermal selection (Fig. 1B). No other nonsynonymous mutations were identiﬁed
within the populations; however, synonymous mutations were identiﬁed in VS53 (i.e.,
2A-G95 [GGC/GGA] and 2A-G101 [GGC/GGG]) and VS57 (i.e., 2C- V47 [GTA/GTG]). The level
of conservation of the two substituted 2Apro residues among enterovirus species was
investigated through the alignment of 2Apro reference sequences of representative mem-
bers, i.e., enteroviruses A, B, C, D, E, F, G, and H and rhinoviruses A, B, and C. This showed
that 2A-I99 is highly conserved among enterovirus C species but varies among other
enteroviruses, while 2A-G102 is highly conserved across all enterovirus species (Fig. 1C).
Because 2Apro is a multifunctional protein that is known to play important roles during
translation (18–20), replication (21, 22), and morphogenesis (5, 26) of PV, we investigated
the signiﬁcance of the mutations selected in 2Apro during adaptation to thermal stress.
Effects of 2A-I99V and 2A-G102R on the cis cleavage activity of 2Apro. The structure
of 2Apro (27) comprises a catalytic triad (14, 15) and highly conserved cysteine and histidine
residues that maintain the catalytic activity and structural integrity of 2Apro, respectively (16,
28). Neither of the 2Apro mutations identiﬁed here involved these residues; however,
proximity to a catalytic residue (C109) could affect activity (13–16, 26). 2Apro has been
shown to autocatalytically cleave the viral polyprotein in cis between tyrosine and glycine
residues at the P1/2A junction (26, 28–31). To investigate this cleavage by the mutant
versions of 2Apro, nonreplicative subgenomic constructs of the P1 region with 2A (i.e.,
P1-2A) were cloned into a pcDNA 3.1() vector (Fig. 2A) and termed pcDNA-P1/2A,
pcDNA-P1/2AI99V, pcDNA-P1-2AG102R, and pcDNA-P1/2AI99V/G102R. These constructs were
expressed using an in vitro coupled transcription/translation (TNT) system under the tran-
scriptional control of a T7 promoter and translated in the presence of [35S]Cys-Met for 90
min at 30°C. Excess unlabeled Cys-Met was then added to prevent further 35S incorporation.
Samples were harvested at 30-minute intervals to assess cis cleavage of the P1-2A sub-
genomic precursor.
We conﬁrmed that the wild-type (wt) precursor P1/2A and also the 2A-I99V con-
struct efﬁciently self-processed to produce P1 and 2A. However, processing of the
2A-G102R construct was severely restricted when this mutation was present individu-
ally or in combination with 2A-I99V (Fig. 2B). Quantitative analyses of the autoradio-
graphs were undertaken, in comparison with processing of the wt proteins. The data
showed that 2A-G102R either alone or in combination with 2A-I99V reduced the
amount of processed P1/2A precursor (Fig. 2C), by 46% and 58%, respectively. The
amount of P1 product from 2A-G102R alone or combination with 2A-I99V was similarly
reduced by 46% and 58%, respectively, over the wt levels (Fig. 2D).
TABLE 1 Recovery of infectious virions with mutations in structural proteins
Capsid mutationa Mutant constructb Recovery of infectious virion
VP1-A26T pT7Rbz-PV1-VP1A26T Yes
VP1-V87A pT7Rbz-PV1-VP1V87A Yes
VP1-S97P pT7Rbz-PV1-VP1S97P Yes
VP1-I194V pT7Rbz-PV1-VP1I194V No
VP3-C175A pT7Rbz-PV1-VP3C175A Yes
VP4-R34S pT7Rbz-PV1-VP4R34S Yes
VP4-D45V pT7Rbz-PV1-VP4D45V Yes
VP4-F46L pT7Rbz-PV1-VP4F46L Yes
aStructural mutations identiﬁed in previously reported thermally selected viruses (34).
bCapsid mutations were individually introduced into cDNA (pT7Rbz-PV1) by site-directed mutagenesis. T7
RNA transcripts were transfected into mouse L cells, and infectious virions recovered were titrated by
plaque assays using HeLa cells (n 3).
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Effects of 2Apro mutations (I99V/G102R) on PV-1 polyprotein processing. Since
the proteolytic activity of 2Apro on the truncated P1-2A polyprotein was affected by the
selected 2Apro mutations (Fig. 2), we investigated downstream effects of the 2Apro
mutations on processing of the full-length viral polyprotein using a HeLa cell-free system
(32, 33). A combination of both 2Apro mutations was introduced into cDNA clone
pT7RbzPV1 using site-directed mutagenesis (SDM) to create pT7RbzPV1-2AI99V/G102R.
RNA transcripts of pT7RbzPV1 or pT7RbzPV1-2AI99V/G102R were translated for 2 h in a
HeLa cell-free lysate in the presence of [35S]Cys-Met. Following a chase with excess
unlabeled Cys-Met, polyprotein processing was assayed by SDS-PAGE and autoradiog-
raphy as shown in lanes 1 to 12 of Fig. 3A. To help identify cleavage products, we
generated predeﬁned proteins from pcDNA 3.1() vectors. Noncleavable P1-P2
(termed pcDNA-P1-P2) and P1-2A (termed pcDNA-P1-2A) were generated by incorpo-
rating the mutation 2A-C109A, which ablates catalytic activity of 2Apro (14). Addition-
ally, subgenomic constructs of P1 only (termed pcDNA-P1) and P2 only (termed
pcDNA-P2) were generated. Subgenomic constructs inserted into pcDNA 3.1() vectors
were expressed in TNT assays and incubated at 30°C for 3 h in the presence of
[35S]Cys-Met. The expressed proteins were used as markers to identify protein band
patterns produced by polyprotein processing as shown in lanes 14 to 17 of Fig. 3A.
FIG 2 Effect of 2Apro mutations on cis-cleavage activity at the P1/2A junction. (A) Cartoon of the construct
used in the transcription/translation (TNT) assay. (B) Autoradiographs of SDS-PAGE of TNT samples.
Following incubation at 30°C for 90 min, further incorporation of [35S]Cys-Met was prevented by the
addition of excess unlabeled Cys-Met and samples collected at 30-minute intervals. Samples were
separated by SDS-PAGE and protein bands detected by autoradiography. Arrows correspond to the
P1/2Apro precursor and processed P1. Time points represent chase. (C and D) Normalized densitometry
of the P1/2Apro precursor (C) and cleaved P1 (D) over time. Graphs represent the intensity of the P1 band
of phosphoscreen scans of autoradiograph. Scanned images were analyzed by ImageJ version 1.47t (n 
2; error bars show standard errors of the means [SEM]; **, P 0.001 compared to wt).
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As shown in lanes 1, 3, 5, 7, 9, and 11 of Fig. 3A, the processing proﬁle and kinetics
for the wt polyprotein followed an expected pattern, with cotranslational release of P1
through autocatalytic cleavage by 2Apro, followed by the processing of P2-P3 and
further processing of P2 and P3 (6, 26). In contrast, the reduced autocatalytic processing
of the polyprotein produced from the mutant construct pT7RbzPV1-2AI99V/G102R re-
sulted in a delayed appearance of several intermediate products, and two large
subgenomic precursor proteins (Fig. 3A, lanes 2, 4, 6, 8, 10 and 12) with sizes similar to
those of uncleaved P1-P2 (lane 14) and P1-2A (lane 15) were detected. To determine
processing rates, band intensities were analyzed using ImageJ. A precursor correspond-
ing to P1-P2, which was seen in mutant 2A-I99V/G102R but not in the wt, was slowly
processed over 24 h (Fig. 3B). A precursor corresponding to P1-2A, which could be
detected in the wt but was more evident in mutant 2A-I99V/G102R, was processed
more slowly in the latter (Fig. 3C). This suggested that 3Cpro/3CDpro processing of these
precursors was less efﬁcient in the mutant 2A-I99V/G102R.
FIG 3 Polyprotein processing of wt and 2Apro mutant PV-1. (A) Both 2A mutations were introduced into
an infectious clone of wt PV-1 (i.e., pt7Rbz). RNA transcripts of pt7Rbz or 2A-I99V/-G102R were used in
HeLa cell-free reactions. Following incubation at 34°C for 2 h, excess Cys-Met was added and samples
taken at various time points. Samples (lanes 1 to 12) were separated by 8% SDS-PAGE and radiolabeled
proteins detected by autoradiography. To identify speciﬁc bands, pcDNA constructs of P1, P2, noncleav-
able P1-2A, and noncleavable P1-P2 were expressed in TNT reactions in the presence of [35S]Cys-Met and
incubated for 3 h (lanes 13 to 17). (B and C) Band intensities were quantiﬁed from a phosphoscreen
image and the levels of P1-P2 (B) and P1-2A (C) presented as normalized percent intensity over
background phosphorescence. Scanned images were analyzed by ImageJ version 1.47t (n 3; error bars
show SEM; *, P 0.05; **, P 0.001 [compared to wt at each time point]).
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Effects of 2Apro mutations (I99V/G102R) on genome replication. It has been
reported that although 2Apro has no direct effect on positive-strand RNA synthesis,
it has a stimulatory role in negative-strand synthesis and thereby could regulate
RNA replication (21). We therefore investigated the effects of the 2Apro mutations
on viral replication using a modiﬁed version of cDNA clone pT7RbzPV-1. Here, the
P1 capsid precursor was replaced with the green ﬂuorescent protein (GFP)-coding
sequence from Ptilosarcus gurneyi, creating a subgenomic replicating replicon,
termed pRepPV1 (Fig. 4A). Both 2Apro mutations were introduced into pRepPV1
individually (to create pRepPV1-2AI99V and pRepPV1-2AG102R) or in combination (to
create pRepPV1-2AI99V/G102R). A replication-deﬁcient construct with a double point
mutation (GDD to GNN) in the 3Dpol active site (34) was used as a control for input
translation. In vitro-transcribed RNAs were generated from the replicon constructs and
transfected into HeLa cells. Replication kinetics were monitored in real time using an
IncuCyte Zoom system as described in Materials and Methods. The data are shown in
Fig. 4A, with endpoint data shown in Fig. 4B for clarity. The 2A-I99V replicon replicated
at levels similar to those of the wt; however, replication of the 2A-G102R or 2A-I99V/
G102R replicon was approximately 100-fold lower than that of the wt (P  0.0001),
although it was still 10-fold higher than the input translation levels of the replication-
deﬁcient GNN replicon (P  0.05). The rate of replication of 2A-I99V was similar to that
of the wt, but there was a lag for 2A-G102R and 2A-I99V/G102R. This shows that the
presence of the 2A-G102R mutation resulted in a signiﬁcant reduction in RNA replica-
tion.
The 2Apro mutations can rescue assembly-defective capsid mutations. In our
previous report, we showed that populations of PV-1 thermally selected at 51°C
possessed two common VP1 mutations (i.e., I194V and V87A) (25), both of which were
FIG 4 Effect of 2Apro mutations on PV-1 replicon replication. (A) HeLa cells were transfected with T7 RNA
transcripts and replication monitored by GFP ﬂuorescence over time using an IncuCyte Zoom. A
replication-deﬁcient mutant, 3D-GNN, was included as a control for input translation. (B) The data from
panel A at 22 h posttransfection (total GFP-positive cells) were also plotted as a bar graph for clarity (n
3; error bars show SEM; *, P 0.05; **, P 0.001; ***, P 0.0001).
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maintained through further selection cycles. We introduced both mutations individu-
ally into pT7Rbz-PV1 and showed that VP1-V87A was compatible with the production
of infectious virions; however, the construct with VP1-I194V could not assemble infec-
tious particles (25). Since both 2Apro mutations were propagated alongside the VP1
mutations during selection (Fig. 1B), we investigated here whether the 2Apro mutations
could rescue the assembly-deﬁcient phenotype of the VP1-I194V mutant.
Infectious clones of PV-1 (pT7Rbz-PV1) with the 2Apro mutations I99V/G102R
(pT7Rbz-PV1-2AI99V/G102R) or the assembly-deﬁcient mutation VP1-I194V alone (pT7Rbz-
PV1-VP1I194V) or in combination with the 2Apro mutations (pT7Rbz-PV1I194V-2AI99V/G102R)
were generated. T7 RNA transcripts of all four constructs were transfected into HeLa
cells or mouse L cells. After 24 h of incubation at 37°C, virus particles were harvested
by freeze-thawing of cells and clariﬁcation of the supernatants. Titers of infectious
virions harvested from both transfected cell lines were determined by plaque assays
using HeLa cells, while thermal stabilities of the recovered virions were assessed as
previously described (25).
The PV-1 titers from L cells and HeLa cells transfected with the construct containing
the 2A-I99V/G102R mutations were reduced by 5 log10 PFU/ml (Fig. 5A) and 3 log10
PFU/ml (Fig. 5B) in comparison with wt, respectively. In the L cells, VP1-I194V alone did
not produce infectious virions, as expected. It should be noted that L cells lack the PV
receptor and therefore support only single-cycle infection. Therefore, virions produced
in HeLa cells were possible revertants ampliﬁed through cell-to-cell spread. Our data
further showed that VP1-I194V in combination with 2A-I99V/G102R resulted in infec-
tious virion titers in both L cells and HeLa cells that were similar to those of infectious
clones with wt P1 and both 2Apro mutations. Furthermore, the thermal inactivation
proﬁle of the recovered virus showed that VP1-I194V-2A-I99V/G102R was more ther-
mally stable than the wt or 2A-I99V/G102R (Fig. 5C). Together, these data suggest that
the mutation VP1-I194V provided thermal stability to the viral capsid, as expected (25),
and that the 2A mutations allowed rescue of this mutant.
To assess the genetic stability of the population, virus mutant VP1-I194V-2A-I99V/
G102R was passaged in the absence of selection pressure using HeLa cells until viral
titers were equivalent to those of the wt. Sequencing of these “restored” virions showed
that the 2Apro second-site (compensatory) mutations had reverted in the absence of
selection pressure (data not shown).
2Apro mutations do not act by reducing translation. Assembly of icosahedral viral
capsids is a complex process which is not yet fully understood. A study with the plant
FIG 5 Effects of 2Apro mutations on virus recovery. RNA transcripts were generated from infectious clones of
the wt or VP1-I194V in the presence or absence of the 2Apro mutations 2A-I99V/-G102R, transfected into
mouse L cells or HeLa cells, and incubated at 37°C for 24 h. (A) Virus titers recovered from transfected mouse
L cells (n  3; error bars show SEM; ***, P 0.0001) (B) Virus titers recovered from transfected HeLa cells.
(n  3; error bars show SEM; ***, P 0.0001) (C) Virus samples recovered from HeLa cells were diluted
in serum-free medium to equal starting titers, incubated at a range of temperatures between 37°C and
55°C for 30 min, cooled to 4°C, and titrated by plaque assays using HeLa cells (n  2; error bars show
standard deviations [SD]; *, P 0.05 compared to wt).
Adeyemi et al. Journal of Virology
March 2019 Volume 93 Issue 5 e01447-18 jvi.asm.org 8
 o
n
 February 27, 2019 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
virus brome mosaic virus suggested that slower translation of the capsid proteins could
result in enhanced assembly (35). In view of these observations, we investigated the
consequences of reducing the translation efﬁciency of the PV-1 infectious clone incor-
porating the VP1-I194V mutation on the recovery of virions.
Cycloheximide is known to inhibit eukaryotic protein synthesis by stopping ribo-
somal elongation during translation (36), and micromolar concentrations of cyclohex-
imide have been shown to shut off PV-1 translation in HeLa cells (37, 38). To determine
whether partial inhibition of translation could replicate the assembly compensatory
effects of the 2Apro mutations, we investigated the effect of reducing/slowing transla-
tion of PV-1 in L cells using low concentrations of cycloheximide. First, we used
conventional cytotoxicity assays to demonstrate a 50% inhibitory concentration (CC50)
of 420 nM in mouse L cells (Fig. 6A). To determine concentrations at which PV
FIG 6 Effects of reduced translation on an assembly-deﬁcient VP1-I194V mutant. (A) Mouse L cells were
treated with increasing concentrations of cycloheximide and assayed for toxicity by using MTS. The IC50
was evaluated by using dose-dependent curves (n  2; error bars show SD). (B) Mouse L cells were
transfected with T7 RNA transcripts of the wt and treated with cycloheximide at increasing concentra-
tions. Cell lysates were harvested using RIPA buffer. Supernatants and cell lysates were separated by
SDS-PAGE and immunoblotted against anti-PV-1 VP1 MAb 8560. Representative results from two
biological repeats are shown. (C) Mouse L cells were transfected with T7 RNA transcripts of the wt and
VP1-I194V mutant and treated at two concentrations of cycloheximide. Supernatants were clariﬁed by
low-speed centrifugation. Virus titers of supernatants from cycloheximide-treated wt- and VP1-I194V
mutant-transfected cells were determined by plaque assays using HeLa cells (n 2; error bars show SEM;
*, P 0.05; ***, P 0.0001 [compared to untreated wt]).
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translation can be reduced but not eliminated, transfected mouse L cells were treated
with increasing concentrations of cycloheximide at 1.5 h posttransfection and incu-
bated at 37°C for 24 h. Cell lysates and supernatants were harvested and immuno-
blotted for viral capsid protein (VP1).
As expected, detection of VP1 decreased as concentrations of cycloheximide increased
(Fig. 6B). We therefore investigated recovery of the assembly-deﬁcient VP1-I194Vmutant by
treating transfected L cells with sublethal concentrations of cycloheximide at 1.5 h post-
transfection. Cells were lysed and clariﬁed, and infectious titers of supernatant samples
were determined by plaque assays. Our data show that treatment with cycloheximide
could not recover the assembly-deﬁcient VP1-I194V mutant (Fig. 6C). Therefore, it appears
that recovery of the assembly-deﬁcient VP1-I194V mutant by 2Apro cannot be replicated by
partial pharmacological inhibition of protein translation.
DISCUSSION
Virions must be sufﬁciently stable to protect their genome from environmental
damage but ﬂexible enough to allow the conformational changes required to deliver
the genome into a new host cell (7, 39). It is likely that changes to this balance, which
might occur during adaptation to unusual environmental stress, will be acquired at a
cost to overall ﬁtness (1, 3).
Previously, we reported that the thermal selection of PV-1 at increasing tempera-
tures of 51°C, 53°C, and 57°C resulted in virus populations that consistently maintained
two VP1 mutations (i.e., I194V and V87A). We further showed by site-directed mutagen-
esis of a wt infectious clone that a combination of VP1-I194V and VP1-V87A increased
the thermal stability of the PV-1 capsid, while VP1-I194V alone abrogated virion
production (25). It has been shown that VP1-I194 in all PV serotypes (or the equivalent
VP1-I192 in PV-3) plays an important role in acquiring resistance to a pocket-binding
antiviral compound, V-073 (40, 41). Additionally, VP1-V87A has been reported to confer
heat resistance to PV-1 (42). Previously, we showed that the selected population
containing both VP1 mutations (I194V and V87A) was more thermally stable than the
wt infectious clone (25). Our ﬁndings suggested that VP1-I194V evolved to complement
VP1-V87A, at a cost to ﬁtness. This was, however, partially compensated for by two
nonstructural protein mutations within the 2Apro region of the genome (2A-I99V and
2A-G102R). We found that both sets of VP1 heat resistance and 2Apro mutations were
maintained together as consensus during further rounds of selection (Fig. 1B and C),
suggesting their importance in maintaining the thermostable phenotype. Here, we
sought to understand the functional and biological consequences of the 2Apro muta-
tions during adaptation.
Multiple roles for 2Apro have been reported, which include antagonizing host
immune responses (13), prolonging viral RNA translation (18, 19), stabilizing replicating
RNA (22), enhancing RNA synthesis (21), and initiating morphogenesis (5). Thus, 2Apro
has been suggested to play a regulatory role in the PV life cycle (13). The autocatalytic
cis-cleavage activity of 2Apro occurs cotranslationally with high efﬁciency (Fig. 2B), while
further polyprotein processing by 3Cpro occurs much less efﬁciently (26). The proteo-
lytic activity of 2Apro can be affected by mutations in the catalytic triad (14, 15) or via
highly conserved cysteine and histidine residues that are known to maintain structural
integrity (16, 27). Although the selected 2Apro mutations did not involve any of these
residues, we hypothesized that proximity of 2A-G102R to a catalytic residue (i.e., C109)
could affect catalytic activity.
The cotranslational cleavage of P1/2A occurs rapidly during normal virus replication.
This appeared to be slower in the rabbit reticulocyte TNT assays used here, which have
also been reported to restrict in vitro translation of poliovirus RNA (43). However, TNT
assays provide a useful platform to investigate posttranslational cleavage kinetics of PV.
Using this approach to investigate the proteolytic efﬁciency of the selected 2Apro
mutations, we observed that 2A-I99V had no effect on the cis cleavage of the pre-
deﬁned P1-2A construct; however, 2A-G102R individually and in combination with
2A-I99V slowed the cis cleavage of P1-2A. We therefore hypothesized that the slower
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processing could have resulted in downstream effects on other aspects of the viral life
cycle, such as delayed release of P1 and 2BC, which could inﬂuence capsid assembly
and/or genome replication.
Using the HeLa cell-free system, we were able to investigate the cis cleavage of the
entire polyprotein by the mutant 2Apro. This showed an accumulation of large precur-
sors, P1-P2 and P1-2A, with an abundance of the former. Both of these precursor
proteins were slowly processed by the protease 3C/3CDpro. The replication of PV has
been shown to involve the formation of a membrane-bound complex of 2B and 2C (9,
10) and 3A (11). We speculate that the delayed release of 2BC may have resulted in
delayed recruitment of 2B and 2C to this replication complex (9, 10), and thus, genome
replication was signiﬁcantly affected (Fig. 4). Given the global change to the order in
which the precursor protein is cleaved, it is perhaps surprising that virus replication is
still supported. Such global changes to how polyproteins are processed could provide
a mechanism by which positive-sense RNA viruses can quickly adapt to selection
pressures via changing the repertoire and order of proteins produced through protease
mutations.
Although we do not fully understand the role of 2A-I99V, the maintenance of this
mutation together with G102R within the consensus sequence prompted our investigation
of the combined effects of both mutations on the VP1-I194V capsid mutant. Our results
suggested that the 2Apro mutations compensated for the assembly-deﬁcient VP1-I194V
mutant (25) (Fig. 5). Together, our data suggest that a combination of 2A-I99V and
2A-G102R modulated the cis-mediated cleavage of P1 (9, 10) and signiﬁcantly decreased
the rates of genome replication to alter the dynamics of virion assembly and overcome the
otherwise deleterious effect of VP1-I194V capsid mutation (44). However, further investi-
gation will be required to fully understand the mechanisms through which the 2Apro
mutations affected replication of the genome.
Assembly of the PV capsid is a complex process requiring highly efﬁcient translation,
which can be lethally affected by deoptimization of the capsid codons (45). In our
previous study we reported that thermal selection of PV-1 (generating variants with
thermally stable capsids) occurred at a cost to virion assembly which was due to a
VP1-I194V mutation. We further speculated that a capsid-stabilizing mutation, VP1-
V87A, could ameliorate the assembly deﬁciency effects of VP1-I194V through unknown
mechanisms (25). Here, we have traced the selection of VP1-I194V to the coexistence
of a pair of second-site (compensatory) mutations within 2Apro, which may have
sustained VP1-I194V within the quasispecies. The role of V87A is unclear, but the
coexistence of I194V and V87A in all subsequently selected heat-resistant viruses
suggests a functional link between these two mutations. Our ﬁndings also showed
that partial inhibition of translation of the polyprotein using cycloheximide could
not recover the assembly-deﬁcient VP1-I194V mutant (Fig. 6); however, reduction of
the rate of polyprotein processing by the mutations (2A-I99V and 2A-G102R)
appeared to favor assembly. Together our ﬁndings suggest that recovery of the
assembly-deﬁcient VP1-I194V mutant by 2Apro may have involved a chaperone-like
activity provided by 2Apro.
Chaperones prevent aggregation of proteins in highly crowded cellular environ-
ments (30, 31) and facilitate viral capsid assembly. Host-encoded chaperones have been
reported for enteroviruses (including PV [46]), hepatitis B virus (47), and bacteriophages
(48, 49). Furthermore, while some virally encoded proteins have also been reported to
have chaperone-like activities that facilitate capsid assembly, e.g., the capsid-associated
protein 80 (p80) of African swine fever virus (50), the T antigen (TAg) of simian virus 40
(SV40) (51), and the nonstructural protein 40 (NSP40) of herpes simplex virus (52).
Early-stage morphogenesis of PV is facilitated by the host-encoded chaperone Hsp70
(46), while virally encoded 2C facilitates later stages of morphogenesis of virions (i.e.,
genome encapsidation) (12, 53–55).
Owing to their small genome sizes, virus-encoded proteins such as 2Apro have been
shown to perform multiple roles. Our study provides the ﬁrst suggestion that PV 2Apro
could act as a chaperone-like protein and suggests regulatory roles for 2Apro in
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maintaining the balance between virus ﬁtness and virion stability that allows the
emergence of heat-resistant PV-1 variants.
MATERIALS AND METHODS
Antibodies. Rabbit polyclonal anti-glyceraldehyde-3-phosphate dehydrogenase (anti-GAPDH)
(G9545) and anti-rabbit polyclonal (A0545) antibodies were commercially sourced from Sigma-Aldrich
(now Merck), Germany. Mouse anti-poliovirus 1 (anti-VP1) monoclonal antibody (MAb) 8560 was com-
mercially sourced from Millipore (now Merck), Germany.
Cell lines and virus propagation. HeLa and mouse L cells were obtained from the National
Institute of Biological Standards and Control, UK. Viruses were propagated by standard methods.
Infectivity titers were determined by plaque assays using HeLa monolayer cells (57) and expressed
as PFU per milliliter.
Viral genome extraction and sequencing. RNA was extracted from virion samples using guani-
dinium thiocyanate-phenol-chloroform (58). The sequence from the 5= UTR to the end of the structural
(P1) coding region (i.e., nucleotide positions 1 to 3385 within the genome) was reverse transcribed and
PCR ampliﬁed using previously described downstream (P1Rev) and upstream (P1Fwd) primers (5=-CTT
GGCCACTCAGGATGATT-3= and 5=-TTAAAACAGCTCTGGGGTTGTAC-3=, respectively) (25). Both structural
and nonstructural regions (i.e., nucleotide positions 1 to 7407 within the genome) were reverse
transcribed and PCR ampliﬁed using downstream (P3Rvs) and upstream (P1Fwd) primers 5=-GTATGAC
CCAATCCAATTCGACT-3= and 5=-TTAAAACAGCTCTGGGGTTGTAC-3=, respectively. PCR amplicons were
sequenced by Sanger methods (59) and cloned into the pGEM-T Easy vector, and individual colonies
were sequenced (60). Primer sequences are available on request.
Recombinant DNA techniques. Poliovirus was recovered from an infectious clone sourced from Bert
Semler, University of California. The full PV-1 (Mahoney) genome was cloned into vector pT7Rbz, which
incorporates a T7 RNA polymerase promoter to allow in vitro RNA synthesis and a ribozyme overhang
(61). For the in vitro assay, the PV-1 P1/2A precursor was cloned into vector pcDNA 3.1() with a Kozak
sequence. Several subgenomic constructs were designed and incorporated into a pcDNA 3.1() vector.
These included pcDNA-P1-2A (which has a wt P1-2A), pcDNA-P1-2AI99V (which has a wt P1 and an I99V
mutation introduced into 2A), pcDNA-P1-2AG102R (which has a wt P1 and a G102R mutation introduced
into 2A), pcDNA-P1-2AI99V/G102R (which has a wt P1 and a combination of I99V and G102R mutations
introduced into 2A), pcDNA-P1-P2 (i.e., a noncleavable P1-P2 construct with a 2A-C109A mutation
introduced), and pcDNA-P1-2A (i.e., a noncleavable P1-P2 construct with a 2A-C109A mutation intro-
duced). All mutations were introduced by SDM (62).
Real-time subgenomic replicon replication assay. Using a previously described PV-1 (strain
Mahoney) cDNA clone (pT7RbzPV-1) (25), a subgenomic replicon was designed and termed pRepPV1-wt.
Here, the P1 capsid precursor was replaced with the green ﬂuorescent protein (GFP)-coding sequence
from Ptilosarcus gurneyi. The modiﬁed pT7RbzGFP replicon incorporated the PV-1 5= UTR, residues 1 to
23 of VP0, ptGFP, the last 25 residues of VP1, the PV P2 region, the P3 region, and the 3= UTR, followed
by the rest of pT7Rbz. Both 2Apro mutations were introduced into pRepPV1 individually (to create
pRepPV1-2AI99V and pRepPV1-2AG102R) or in combination (to create pRepPV1-2AI99V/G102R) by SDM (62).
pRepPV1 was linearized using EcoRI and RNA transcribed in vitro by T7 RNA polymerase (63). One-
microgram aliquots of RNA transcripts were transfected into HeLa cells using Lipofectin. Replicon
replication was assessed in real time as GFP expression by live-cell imaging within the IncuCyte
dual-color Zoom, which is an automated phase-contrast and ﬂuorescence microscope within a 37°C
humidifying CO2 incubator. Cells were monitored every 30 min posttransfection for up to 24 h. Nine
images per well were taken at each time to measure the GFP object counts per well, as well as the total
ﬂuorescence intensity per well using an integrated software, and analyzed according to standard
methods (64).
In vitro TNT assay. (i) Rabbit reticulocyte lysates. Subgenomic PV-1 constructs were cloned into
the pcDNA 3.1() vector individually (i.e., pcDNA-P1-2A, pcDNA-P1-2AI99V, and pcDNA-P1-2AG102R) or in
combination (i.e., pcDNA-P1-2AI99V/G102R) and expressed in the TNT Quick coupled transcription/transla-
tion (TNT) system (Promega) in the presence of [35S]Cys-Met according to the manufacturer’s protocol.
Following an incubation period of 90 min at 30°C, further incorporation of 35S was prevented by addition
of excess unlabeled Cys-Met, and samples were taken at intervals of 30 min. Proteins were separated by
SDS-PAGE (65) and detected by autoradiography (66) and phosphorimaging (67).
(ii) HeLa cell-free extracts. HeLa cell (S10) extracts and initiation factor (IF) fractions were gifted by David
Barton, University of Colorado and also were prepared according to standard protocols (33, 68). Reaction
mixtures contained 50% (vol/vol) S10, 20% (vol/vol) IF, 10% (vol/vol) 10 reaction buffer (10mM ATP, 2.5mM
GTP, 2.5mM CTP, 2.5mM UTP, 600mM KCH3CO2, 300mM creatine phosphate, 4mg/ml creatine kinase, and
155mM HEPES-KOH [pH 7.4]), 3.2g T7 RNA transcripts, and 38 Ci [35S]Cys-Met. Reaction mixtures were
incubated at 34˚C for 2 h and chased with excess amounts of unlabeled Cys-Met. Sample proteins were
separated by 8% SDS-PAGE, and [35S]Cys-Met-labeled proteins were detected by standard protocols for
autoradiography (66) and phosphorimaging (67).
Virus recovery from infectious clones. A total of 2.5 106 mouse L cells or HeLa cells were
transfected with 5 g of RNA transcripts using Lipofectin according to the manufacturer’s protocols.
Transfected cells were incubated at 37°C for 16 h and cell harvests titrated for infectivity after disruption
by freeze-thawing.
Cycloheximide cytotoxicity assay. The compound 4-(2-hydroxyethyl) piperidine-2,6-dione, also
known as cycloheximide, was commercially sourced from Sigma-Aldrich (now Merck), Germany.
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Cell culture 96-well vessels were seeded to 4 104 cells per well. Triplicate wells of seeded cells
were treated with cycloheximide at increasing concentrations. Cells were incubated at 37°C under 5%
CO2 for 24 h and assayed for toxicity using a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay kit (Promega CellTiter 96 Aqueous One Solution Cell
Proliferation) according to the manufacturers’ protocol.
Translation inhibition assays.Mouse L cells were transfected with 3 g T7 RNA transcripts of a PV-1
infectious clone, pT7Rbz. At 1.5 h posttransfection, cycloheximide was added to the indicated concen-
trations. Cells were incubated at 37°C under 5% CO2 and harvested after 24 h. Supernatants from each
well were clariﬁed by centrifugation at 4,000 rpm for 2 min. Cells were trypsinized, washed, and lysed
using radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-Cl [pH 7.4], 150 mM NaCl, 1% NP-40,
0.5% sodium deoxycholate, 0.1% SDS). Proteins were separated by 8% SDS-PAGE (65) and immuno-
blotted using an anti-VP1 MAb (69) by standard protocols.
Densitometry. Scanned images were analyzed by ImageJ (70) version 1.47t according to standard
procedures. Brieﬂy, scanned image blots or phosphoscreened autoradiographs were saved in the Tagged
Image File Format (TIFF). Selected bands of interest were individually selected, and pixilated band
intensities were quantiﬁed according to software algorithms.
Genome sequences and alignment. Reference genome sequences of the following viruses were
sourced from GenBank and downloaded in the FASTA format: coxsackievirus A1 (CVA-1) (AGI61097.1),
echovirus 1 (EV1) (AAC63944.2), PV-1 (P03300), PV-2 (AAA46912.1), PV-3 (AAN85444.1), CVA-2
(ANQ47259.1), enterovirus 94 (EV-94) (ABL61316.1), bovine enterovirus 1 (BEV-1) (P12915.3), BEV-2
(ADU34211.1), EV-G1 (AIA21703.1), SV4 (AAL69631.2), human rhinovirus A (HRV-A) (CAA26181.1), HRV-B
(ACK37380.1), and HRV-C (ABK29455.2). Alignment of sequences was carried out at the protein level
using the MUltiple Sequence Comparison by Log-Expectation (MUSCLE) algorithm of the CLC Sequence
Viewer version 7.8.1 software.
Statistical analysis. Statistical analysis of mutants against the wt was done with Student t tests using
GraphPad Prism version 7.01 for Windows (GraphPad Software, La Jolla CA).
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